Latest filing published 20 Dec 2024 for 동성제약.
이양구 is a declared insider of 동성제약, with filings sourced from DART (FSS). Between 12 May 2021 and 18 December 2024, the trades on record add up to 27 filings.
The open-market record is one-sided, with 23 purchases and not one sale. The totals do not cover 23 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2024 alone, the filings show 3 purchases and no sales.
Across 23 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The latest filing, published on 20 December 2024, reports a transaction in 동성제약. The most recent open-market purchase was published on 20 September 2024, 765 days ago. The median gap between a trade and its publication by DART (FSS) is 2 days. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 27 declarations